[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 48, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1097468, "exercisedValue": 0, "unexercisedValue": 469825}, {"maxAge": 1, "name": "Mr. Alexander Mark Schobel", "age": 65, "title": "Chief Innovation & Technology Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 2595296, "exercisedValue": 0, "unexercisedValue": 324350}, {"maxAge": 1, "name": "Ms. Lori J. Braender BSBA, Esq., J.D.", "age": 68, "title": "Chief Legal Officer, Chief Compliance Officer & Secretary", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 737771, "exercisedValue": 0, "unexercisedValue": 255600}, {"maxAge": 1, "name": "Mr. A. Ernest Toth Jr.", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 667187, "exercisedValue": 0, "unexercisedValue": 11400}, {"maxAge": 1, "name": "Ms. Cassie  Jung", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "age": 54, "title": "Senior Vice President of Sales & Marketing", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 58, "title": "Senior Vice President of Information Technology & Human Resources", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl N. Kraus M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Melina T. Cioffi", "age": 41, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 5, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.79, "open": 2.77, "dayLow": 2.64, "dayHigh": 2.77, "regularMarketPreviousClose": 2.79, "regularMarketOpen": 2.77, "regularMarketDayLow": 2.64, "regularMarketDayHigh": 2.77, "payoutRatio": 0.0, "beta": 2.018, "forwardPE": -4.5166664, "volume": 741025, "regularMarketVolume": 741025, "averageVolume": 1433584, "averageVolume10days": 1295900, "averageDailyVolume10Day": 1295900, "bid": 1.98, "ask": 3.41, "bidSize": 2, "askSize": 2, "marketCap": 269178624, "fiftyTwoWeekLow": 2.12, "fiftyTwoWeekHigh": 5.8, "priceToSalesTrailing12Months": 4.963831, "fiftyDayAverage": 2.7198, "twoHundredDayAverage": 3.71675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 239656688, "profitMargins": -1.0001999, "floatShares": 93521217, "sharesOutstanding": 99327904, "sharesShort": 9840455, "sharesShortPriorMonth": 9870823, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.0991, "heldPercentInsiders": 0.05567, "heldPercentInstitutions": 0.48861, "shortRatio": 6.38, "shortPercentOfFloat": 0.1175, "impliedSharesOutstanding": 99327904, "bookValue": -0.613, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -54239000, "trailingEps": -0.58, "forwardEps": -0.6, "enterpriseToRevenue": 4.419, "enterpriseToEbitda": -5.917, "52WeekChange": -0.078231275, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 2.71, "targetHighPrice": 15.0, "targetLowPrice": 4.75, "targetMeanPrice": 8.41667, "targetMedianPrice": 8.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 68657000, "totalCashPerShare": 0.691, "ebitda": -40506000, "totalDebt": 39135000, "quickRatio": 4.323, "currentRatio": 4.873, "totalRevenue": 54228000, "revenuePerShare": 0.588, "returnOnAssets": -0.22209999, "grossProfits": 37093000, "freeCashflow": -20214250, "operatingCashflow": -48775000, "revenueGrowth": -0.277, "grossMargins": 0.68402, "ebitdaMargins": -0.74696, "operatingMargins": -2.22076, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "postMarketChangePercent": 0.0, "postMarketPrice": 2.71, "postMarketChange": 0.0, "regularMarketChange": -0.0799999, "regularMarketDayRange": "2.64 - 2.77", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1433584, "fiftyTwoWeekLowChange": 0.59000015, "fiftyTwoWeekLowChangePercent": 0.27830198, "fiftyTwoWeekRange": "2.12 - 5.8", "fiftyTwoWeekHighChange": -3.0900002, "fiftyTwoWeekHighChangePercent": -0.53275865, "fiftyTwoWeekChangePercent": -7.8231277, "earningsTimestamp": 1747080061, "earningsTimestampStart": 1754424000, "earningsTimestampEnd": 1754424000, "earningsCallTimestampStart": 1747137600, "earningsCallTimestampEnd": 1747137600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.58, "epsForward": -0.6, "epsCurrentYear": -0.68667, "priceEpsCurrentYear": -3.9465828, "fiftyDayAverageChange": -0.009799957, "fiftyDayAverageChangePercent": -0.0036031904, "twoHundredDayAverageChange": -1.0067499, "twoHundredDayAverageChangePercent": -0.27086833, "priceToBook": -4.4208813, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Aquestive Therapeutics, Inc.", "longName": "Aquestive Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1748648761, "regularMarketTime": 1748635201, "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.86738, "regularMarketPrice": 2.71, "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]